About NeXtGen Biologics
NeXtGen Biologics is a private company based in Alachua, Florida. It has reported $2,890,500 raised in six offerings on Form D since September 2014. Its chief executive is Jonelle Toothman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | Sep 22, 2025 | $130,000of $5.0M target | 3 | $43,333 | EquityRule 506(b) | Form D ↗ |
| Jul 22, 2019 | Aug 17, 2020 | $100,000target not set | 1 | $100K | EquityRule 506(b) | Form D ↗ |
| Dec 13, 2018 | Dec 27, 2018 | $2,160,500target not set | 19 | $113K | Equity, DebtRule 506(c) | Form D ↗ |
| Not yet | Jun 16, 2016amended May 24, 2017 | $0target not set | 0 | — | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | Nov 23, 2015 | $0of $1.5M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Aug 18, 2014 | Sep 24, 2014 | $500,000of $1.0M target | 2 | $250K | DebtRule 506(b) | Form D ↗ |
| Total, six offerings | $2,890,500 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NeXtGen Biologics's Form D filed Sep 22, 2025.
EL
Elad Levy
Director
RW
Rick Wassel
Director
GK
Gerald Kluft
Director
JT
Jonelle Toothman
CEO and director
JG
Jamie Grooms
Director
DH
Dan Hamister
Director
BL
Brian Lipke
Director
Earlier filings also listed Mark Hamister (director, last listed Dec 2018) and Mark Gold (director, last listed Dec 2018).